Key facts
- It has raised $50K; the latest was Seed Round in Apr 2025.
- Notable investors include MedTech Innovator, Blueprint Medtech, Device of Tomorrow Capital, EvoNexus, SmartGateVC — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Vonova
- ·The full record, as it builds
Funding rounds
No funding rounds for Vonova are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vonova
Developer of a neurovascular device designed to treat chronic subdural hematomas with a less invasive approach. The company offers a vein-based system that eliminates the need for skull drilling, enabling neurosurgeons to improve patient outcomes and support faster recovery.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2022
- Employees
- 6
- Website
- vonova.io/
- Ownership
- Privately Held (backing)
Vonova doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vonova shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vonova in its N-PORT filings yet. We sweep new filings monthly.